METASTATIC KIDNEY MEDULLARY CARCINOMA
Clinical trials for METASTATIC KIDNEY MEDULLARY CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new METASTATIC KIDNEY MEDULLARY CARCINOMA trials appear
Sign up with your email to follow new studies for METASTATIC KIDNEY MEDULLARY CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Immunotherapy drug shows promise for rare and Hard-to-Treat cancers
Disease control OngoingThis study tests a drug called pembrolizumab (Keytruda) in 157 people with rare cancers that have spread or cannot be removed. The drug helps the immune system fight cancer by blocking a protein that tumors use to hide. The main goal is to see if the drug can stop the cancer from…
Matched conditions: METASTATIC KIDNEY MEDULLARY CARCINOMA
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated May 26, 2026 11:08 UTC
-
Promising drug cocktail targets rare, aggressive kidney cancer
Disease control OngoingThis study tests a combination of three drugs (ixazomib, gemcitabine, and doxorubicin) in 30 people with a rare and aggressive kidney cancer that has spread. The goal is to see if the treatment can shrink tumors or stop them from growing. Participants receive the drugs in cycles,…
Matched conditions: METASTATIC KIDNEY MEDULLARY CARCINOMA
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated May 15, 2026 11:53 UTC